Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Weingartner, Herbert
Kaye, Walter
Gold, Philip
Smallberg, Sheila
Peterson, Ron
Gillin, J.C.
and
Ebert, Michael
1981.
Vasopressin treatment of cognitive dysfunction un progressive dementia.
Life Sciences,
Vol. 29,
Issue. 26,
p.
2721.
ROBERTS, EUGENE
1982.
Potential Therapies in Aging and Senile Dementias*.
Annals of the New York Academy of Sciences,
Vol. 396,
Issue. 1,
p.
165.
Bartus, Raymond T.
Dean, Reginald L.
Beer, Bernard
and
Lippa, Arnold S.
1982.
The Cholinergic Hypothesis of Geriatric Memory Dysfunction.
Science,
Vol. 217,
Issue. 4558,
p.
408.
Chuaqui, Paz
and
Levy, Raymond
1982.
Fluctuations of Free Choline Levels in Plasma of Alzheimer Patients Receiving Lecithin: Preliminary Observations.
British Journal of Psychiatry,
Vol. 140,
Issue. 5,
p.
464.
Mann, D M
Yates, P O
and
Hawkes, J
1982.
The noradrenergic system in Alzheimer and multi-infarct dementias..
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 45,
Issue. 2,
p.
113.
Marchbanks, R. M.
1982.
Biochemistry of Alzheimer's Dementia.
Journal of Neurochemistry,
Vol. 39,
Issue. 1,
p.
9.
Spar, James E.
1982.
Dementia in the Aged.
Psychiatric Clinics of North America,
Vol. 5,
Issue. 1,
p.
67.
Rosenberg, GS
and
Davis, KL
1982.
The use of cholinergic precursors in neuropsychiatric diseases.
The American Journal of Clinical Nutrition,
Vol. 36,
Issue. 4,
p.
709.
1982.
Enhancement of memory processes in Alzheimer's disease with multiple- dose intravenous physostigmine.
American Journal of Psychiatry,
Vol. 139,
Issue. 11,
p.
1421.
Mohs, Richard C.
and
Davis, Kenneth L.
1982.
A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease.
Neurobiology of Aging,
Vol. 3,
Issue. 2,
p.
105.
Blass, John P.
1982.
Dementia.
Medical Clinics of North America,
Vol. 66,
Issue. 5,
p.
1143.
Dowson, J.H.
1982.
Pharmacological treatment of chronic cognitive deficit: A review.
Comprehensive Psychiatry,
Vol. 23,
Issue. 1,
p.
85.
Coyle, Joseph T.
Price, Donald L.
and
DeLong, Mahlon R.
1983.
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation.
Science,
Vol. 219,
Issue. 4589,
p.
1184.
BLASS, JOHN P.
and
WEKSLER, MARC E.
1983.
Toward an Effective Treatment of Alzheimer's Disease.
Annals of Internal Medicine,
Vol. 98,
Issue. 2,
p.
251.
GREENWALD, BLAINE S.
MOHS, RICHARD C.
and
DAVIS, KENNETH L.
1983.
Neurotransmitter Deficits in Alzheimer's Disease: Criteria for Significance.
Journal of the American Geriatrics Society,
Vol. 31,
Issue. 5,
p.
310.
1983.
Memory Enhancement with Oral Physostigmine in Alzheimer's Disease.
New England Journal of Medicine,
Vol. 308,
Issue. 12,
p.
720.
Wong, Normund
1983.
Fundamental Psychoanalytic Concepts: Past and Present Understanding of Their Applicability to Group Psychotherapy.
International Journal of Group Psychotherapy,
Vol. 33,
Issue. 2,
p.
171.
Brinkman, Samuel D.
and
Gershon, Samuel
1983.
Measurement of cholinergic drug effects on memory in alzheimer's disease.
Neurobiology of Aging,
Vol. 4,
Issue. 2,
p.
139.
CHRISTIE, JANICE E.
WHALLEY, LAWRENCE J.
DICK, HEINZ
and
FINK, GEORGE
1983.
Hormonal Steroids.
p.
247.
Christie, Janice E.
Whalley, Lawrence J.
Dick, Heinz
and
Fink, George
1983.
Plasma cortisol concentrations in the functional psychoses and Alzheimer Type Dementia: A neuroendocrine day approach in drug-free patients.
Journal of Steroid Biochemistry,
Vol. 19,
Issue. 1,
p.
247.
eLetters
No eLetters have been published for this article.